Azimuth Pharma Limited - Limited company - abbreviated - 11.6
Azimuth Pharma Limited - Limited company - abbreviated - 11.6
| REGISTERED NUMBER: |
| Abbreviated Unaudited Accounts for the Year Ended 31 March 2015 |
| for |
| Azimuth Pharma Limited |
| Azimuth Pharma Limited (Registered number: 07916512) |
| Contents of the Abbreviated Accounts |
| for the Year Ended 31 March 2015 |
| Page |
| Company Information | 1 |
| Abbreviated Balance Sheet | 2 |
| Notes to the Abbreviated Accounts | 3 |
| Azimuth Pharma Limited |
| Company Information |
| for the Year Ended 31 March 2015 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Azimuth Pharma Limited (Registered number: 07916512) |
| Abbreviated Balance Sheet |
| 31 March 2015 |
| 31.3.15 | 31.3.14 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Investments | 2 |
| CURRENT ASSETS |
| Cash at bank |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 3 |
| Profit and loss account |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| The financial statements were approved by the Board of Directors on |
| G Smith - Director | M Stanton - Director |
| S Bennett - Director |
| Azimuth Pharma Limited (Registered number: 07916512) |
| Notes to the Abbreviated Accounts |
| for the Year Ended 31 March 2015 |
| 1. | ACCOUNTING POLICIES |
| Accounting convention |
| The financial statements have been prepared under the historical cost convention and in accordance with the |
| Financial Reporting Standard for Smaller Entities (effective April 2008). |
| Preparation of consolidated financial statements |
| The financial statements contain information about Azimuth Pharma Limited as an individual company and do |
| not contain consolidated financial information as the parent of a group. The company has taken the option under |
| Section 398 of the Companies Act 2006 not to prepare consolidated financial statements. |
| 2. | FIXED ASSET INVESTMENTS |
| Investments |
| other |
| than |
| loans |
| £ |
| COST |
| At 1 April 2014 |
| and 31 March 2015 |
| NET BOOK VALUE |
| At 31 March 2015 |
| At 31 March 2014 |
| The company's investments at the Balance Sheet date in the share capital of companies include the following: |
| Nature of business: |
| % |
| Class of shares: | holding |
| Ordinary | 100.00 |
| £ | £ |
| Aggregate capital and reserves | 686,769 | 700,917 |
| Profit for the year | 119,326 | 144,519 |
| Nature of business: |
| % |
| Class of shares: | holding |
| Ordinary | 100.00 |
| Nature of business: |
| % |
| Class of shares: | holding |
| Ordinary | 60.00 |
| 3. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 31.3.15 | 31.3.14 |
| value: | £ | £ |
| Ordinary | .01 |